Chemoinformaics analysis of Hesperidin-7-O-Alpha-L-Rhamno-Glucoside
Molecular Weight | 610.565 | nRot | 7 |
Heavy Atom Molecular Weight | 576.293 | nRig | 30 |
Exact Molecular Weight | 610.19 | nRing | 5 |
Solubility: LogS | -3.504 | nHRing | 3 |
Solubility: LogP | -0.59 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 77 | No. of Aliphatic Hetero Cycles | 3 |
No. of Heavy Atom | 43 | No. of Aromatic Carbocycles | 2 |
nHetero | 15 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 28 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 15 | No. of Arom Bond | 12 |
nHA | 15 | APOL | 81.461 |
nHD | 8 | BPOL | 45.393 |
QED | 0.185 |
Synth | 4.818 |
Natural Product Likeliness | 1.945 |
NR-PPAR-gamma | 0.958 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.994 |
HIA | 0.953 |
CACO-2 | -6.484 |
MDCK | 0.000094 |
BBB | 0.254 |
PPB | 0.776403 |
VDSS | 0.395 |
FU | 0.205182 |
CYP1A2-inh | 0.003 |
CYP1A2-sub | 0.06 |
CYP2c19-inh | 0.014 |
CYP2c19-sub | 0.295 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.507 |
CYP2d6-inh | 0.014 |
CYP2d6-sub | 0.207 |
CYP3a4-inh | 0.016 |
CYP3a4-sub | 0.046 |
CL | 1.489 |
T12 | 0.195 |
hERG | 0.022 |
Ames | 0.499 |
ROA | 0.084 |
SkinSen | 0.03 |
Carcinogencity | 0.87 |
EI | 0.008 |
Respiratory | 0.06 |
NR-Aromatase | 0.433 |
Antiviral | Yes |
Prediction | 0.868875 |